FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913574235> ?p ?o ?g. }

• W2913574235 endingPage "46" @default.
• W2913574235 startingPage "42" @default.
• W2913574235 abstract "Plasma cell-rich acute rejection is an aggressive form of acute rejection that occurs late after transplant and is usually resistant to standard antirejection therapy. This study reports the safety, efficacy, and outcomes of plasma cell-rich acute rejection after treatment with bortezomib, a proteasome inhibitor, in 10 patients after a first living-related renal transplant.Plasma cell-rich acute rejection was diagnosed using the 2007 Banff classification. The treatment protocol for plasma cell-rich acute rejection included methylprednisolone (500 mg/kg), 7 sessions of plasmapheresis, antithymocyte globulin (3-5 mg/kg/day for 10 days), rituximab (2 doses at 375 mg/m2), and bortezomib (1 cycle at 1.3 mg/m2).The mean age of recipients and donors was 23.70 ± 11.39 and 37.30 ± 12.82 years, respectively. The mean time to plasma cell-rich acute rejection was 3.1 ± 2.5 years. The mean serum creatinine level at rejection was 4.8 ± 2.7 mg/dL. After treatment, serum creatinine decreased to 3.3 ± 1.8 mg/dL. Serum creatinine levels at 1-year and 2-year follow-up were 3.0 ± 2.3 and 3.3 ± 0.9 mg/dL, respectively. There was 1 graft failure due to recurrence of glomerulonephritis/de novo glomerulonephritis. No significant adverse effects were noted in the patients. Bortezomib successfully reverted plasma cell-rich acute rejection and stabilized graft function, with patients showing 2-year graft survival after rejection of 90%.Bortezomib-based treatment was successful in reverting plasma cell-rich acute rejection and stabilizing graft function, with graft survival of 90% at 2 years. Further studies with large cohorts and randomized trials with or without bortezomib will help in better evaluation of its efficacy, safety, and outcomes." @default.
• W2913574235 created "2019-02-21" @default.
• W2913574235 creator A5002406316 @default.
• W2913574235 creator A5007604306 @default.
• W2913574235 creator A5014088328 @default.
• W2913574235 creator A5042315514 @default.
• W2913574235 creator A5044160040 @default.
• W2913574235 creator A5065882552 @default.
• W2913574235 creator A5088861974 @default.
• W2913574235 date "2019-02-01" @default.
• W2913574235 modified "2023-10-18" @default.
• W2913574235 title "Management of Plasma Cell-Rich Acute Rejection in Living-Related Kidney Transplant: Role of Proteasome Inhibitor" @default.
• W2913574235 cites W1506151781 @default.
• W2913574235 cites W1506252195 @default.
• W2913574235 cites W1581930806 @default.
• W2913574235 cites W1737600104 @default.
• W2913574235 cites W1833426310 @default.
• W2913574235 cites W1941153199 @default.
• W2913574235 cites W1986544936 @default.
• W2913574235 cites W1989898047 @default.
• W2913574235 cites W1995791071 @default.
• W2913574235 cites W1996635899 @default.
• W2913574235 cites W2009536422 @default.
• W2913574235 cites W2018006390 @default.
• W2913574235 cites W2019518088 @default.
• W2913574235 cites W2061733861 @default.
• W2913574235 cites W2089171359 @default.
• W2913574235 cites W2096206672 @default.
• W2913574235 cites W2110079652 @default.
• W2913574235 cites W2123039592 @default.
• W2913574235 cites W2134812738 @default.
• W2913574235 cites W2143296077 @default.
• W2913574235 cites W2147340881 @default.
• W2913574235 cites W2342949287 @default.
• W2913574235 cites W2343231073 @default.
• W2913574235 cites W2525095138 @default.
• W2913574235 doi "https://doi.org/10.6002/ect.2017.0154" @default.
• W2913574235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29534661" @default.
• W2913574235 hasPublicationYear "2019" @default.
• W2913574235 type Work @default.
• W2913574235 sameAs 2913574235 @default.
• W2913574235 citedByCount "9" @default.
• W2913574235 countsByYear W29135742352019 @default.
• W2913574235 countsByYear W29135742352020 @default.
• W2913574235 countsByYear W29135742352021 @default.
• W2913574235 countsByYear W29135742352022 @default.
• W2913574235 crossrefType "journal-article" @default.
• W2913574235 hasAuthorship W2913574235A5002406316 @default.
• W2913574235 hasAuthorship W2913574235A5007604306 @default.
• W2913574235 hasAuthorship W2913574235A5014088328 @default.
• W2913574235 hasAuthorship W2913574235A5042315514 @default.
• W2913574235 hasAuthorship W2913574235A5044160040 @default.
• W2913574235 hasAuthorship W2913574235A5065882552 @default.
• W2913574235 hasAuthorship W2913574235A5088861974 @default.
• W2913574235 hasConcept C126322002 @default.
• W2913574235 hasConcept C126894567 @default.
• W2913574235 hasConcept C159641895 @default.
• W2913574235 hasConcept C159654299 @default.
• W2913574235 hasConcept C197934379 @default.
• W2913574235 hasConcept C203014093 @default.
• W2913574235 hasConcept C2776364478 @default.
• W2913574235 hasConcept C2776396001 @default.
• W2913574235 hasConcept C2777478702 @default.
• W2913574235 hasConcept C2778367456 @default.
• W2913574235 hasConcept C2778842783 @default.
• W2913574235 hasConcept C2779338263 @default.
• W2913574235 hasConcept C2780306776 @default.
• W2913574235 hasConcept C2780372218 @default.
• W2913574235 hasConcept C2780472472 @default.
• W2913574235 hasConcept C2780653079 @default.
• W2913574235 hasConcept C2911091166 @default.
• W2913574235 hasConcept C71924100 @default.
• W2913574235 hasConcept C90924648 @default.
• W2913574235 hasConceptScore W2913574235C126322002 @default.
• W2913574235 hasConceptScore W2913574235C126894567 @default.
• W2913574235 hasConceptScore W2913574235C159641895 @default.
• W2913574235 hasConceptScore W2913574235C159654299 @default.
• W2913574235 hasConceptScore W2913574235C197934379 @default.
• W2913574235 hasConceptScore W2913574235C203014093 @default.
• W2913574235 hasConceptScore W2913574235C2776364478 @default.
• W2913574235 hasConceptScore W2913574235C2776396001 @default.
• W2913574235 hasConceptScore W2913574235C2777478702 @default.
• W2913574235 hasConceptScore W2913574235C2778367456 @default.
• W2913574235 hasConceptScore W2913574235C2778842783 @default.
• W2913574235 hasConceptScore W2913574235C2779338263 @default.
• W2913574235 hasConceptScore W2913574235C2780306776 @default.
• W2913574235 hasConceptScore W2913574235C2780372218 @default.
• W2913574235 hasConceptScore W2913574235C2780472472 @default.
• W2913574235 hasConceptScore W2913574235C2780653079 @default.
• W2913574235 hasConceptScore W2913574235C2911091166 @default.
• W2913574235 hasConceptScore W2913574235C71924100 @default.
• W2913574235 hasConceptScore W2913574235C90924648 @default.
• W2913574235 hasIssue "1" @default.
• W2913574235 hasLocation W29135742351 @default.
• W2913574235 hasLocation W29135742352 @default.
• W2913574235 hasOpenAccess W2913574235 @default.
• W2913574235 hasPrimaryLocation W29135742351 @default.
• W2913574235 hasRelatedWork W1486584413 @default.

• next